Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events
11 December 2020 (00:00 - 00:00)
Organised by:
About the speaker
Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)
9 More presentations in this session
Doctor V. Kamperidis (Thessaloniki, GR)
Doctor M. Mazzola (Pisa, IT)
Echocardiographic features and behavior of cardiac structural abnormalities in mucopolysaccharidosis
Doctor S. Saba (Wolverhampton, GB)
Access the full session
The Event
EACVI - Best of Imaging 2020
11 December - 12 December 2020
You may be interested in
Congress Presentation
